$6.18
-0.45-6.79%
Last update: Nov 4, 5:32 PM
aTyr Pharma Inc
ATYRNASDAQ
The average analyst price target for aTyr Pharma is $60, 883.6% above the current price. Of 8 analysts, 2 rate it Buy and 6 Hold. Targets range from $40 to $140. The latest change came on May 20, 2026, when Freedom Broker upgraded aTyr Pharma from Hold to Buy and moved its price target from $40 to $140.
Price Target Range — 9 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
